Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
03/2014
03/05/2014CN103613527A N,N-substituted 3-aminopyrrolidine compound capable of being used as monoamine reuptake inhibitor
03/05/2014CN102498091B Glycine compound
03/05/2014CN101835757B Diacylglycerol acyltransferase inhibitors
03/05/2014CN101701006B Phenethanolamine derivatives for treatment of respiratory diseases
03/04/2014US8664399 Substituted heterocyclic compounds as ion channel modulators
03/04/2014US8664380 Heterocyclic compound and use thereof
03/04/2014US8664379 Fused heterocyclic compounds as ion channel modulators
02/2014
02/27/2014WO2014031971A1 Herbicidal pyridazinones
02/27/2014WO2014031936A2 Heterocyclic modulators of hif activity for treatment of disease
02/27/2014WO2014031933A2 Heterocyclic modulators of hif activity for treatment of disease
02/27/2014WO2014031928A2 Heterocyclic modulators of hif activity for treatment of disease
02/27/2014WO2014031784A1 Compounds for the treatment of paramoxyvirus viral infections
02/27/2014WO2014030743A1 Heterocycic compound
02/27/2014WO2014030001A1 Fused heterocyclic compounds and their use
02/27/2014WO2014029832A1 Substituted 4-pyridones and their use as inhibitors of neutrophil elastase activity
02/27/2014WO2014029831A1 Substituted 4-pyridones and their use as inhibitors of neutrophil elastase activity
02/27/2014WO2014029830A1 Substituted 4-pyridones and their use as inhibitors of neutrophil elastase activity
02/27/2014WO2014029684A1 Pesticidally active pyridyl- and pyrimidyl- substituted pyrazole derivatives
02/27/2014WO2014029333A1 Substituted oxazolidinone compound and pharmaceutical composition comprising the compound and use thereof
02/27/2014WO2014029193A1 Dihydropyrimidine compounds and their application in pharmaceuticals
02/27/2014WO2014029007A1 Protein kinase inhibitors
02/27/2014WO2014008257A3 Processes for the preparation of 3,5-disubstituted-1,2,4-oxadiazoles
02/27/2014US20140058105 Substituted diketopiperazines and their use as oxytocin antagonists
02/27/2014US20140058100 Tetrahydroisoquinolin-1-one derivative or salt thereof
02/27/2014US20140057951 Substituted oxazolidinones and their use
02/27/2014US20140057926 Substituted 4-pyridones and their use as inhibitors of neutrophil elastase activity
02/27/2014US20140057920 Substituted 4-pyridones and their use as inhibitors of neutrophil elastase activity
02/27/2014US20140057916 Substituted 4-pyridones and their use as inhibitors of neutrophil elastase activity
02/27/2014US20140057914 Heterocyclic modulators of hif activity for treatment of disease
02/27/2014US20140057895 Indazole- and pyrrolopyridine-derivative and pharmaceutical use thereof
02/27/2014US20140057893 Substituted cycloproply compounds, compositions containing such compounds and methods of treatment
02/27/2014US20140057890 Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
02/27/2014US20140057889 Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
02/27/2014US20140057882 Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors
02/27/2014US20140056880 Triazole compounds as ksp inhibitors
02/27/2014CA2876690A1 Dihydropyrimidine compounds and their application in pharmaceuticals
02/26/2014EP2699580A2 Diazonamide analogs
02/26/2014EP2699568A1 A crystalline form of a salt of a morpholino sulfonyl indole derivative and a process for its preparation
02/26/2014EP2699567A1 Insulin-like growth factor-1 receptor inhibitors
02/26/2014EP2699566A1 Phenyl-isoxazol derivatives and preparation process thereof
02/26/2014EP2699565A1 Fatty acid amide hydrolase inhibitors for treating pain
02/26/2014EP2699561A1 Androgen receptor modulating carboxamides
02/26/2014EP2699560A2 5-carbamoyl-adamantan-2-yl amide derivatives, pharmaceutically acceptable salts thereof and preparation process thereof
02/26/2014EP2699547A1 5-(phenyl/pyridinyl-ethinyl)-2-pyridine/ 2-pyrimidine-carborxamides as mglur5 modulators
02/26/2014CN103608345A Oxazine derivative and BACE 1 inhibitor containing same
02/26/2014CN103608344A [1,3]oxazines
02/26/2014CN103608335A Pyrimidine derivatives for the treatment of viral infections
02/26/2014CN103608332A Pyridin-2-amides useful as CB2 agonists
02/26/2014CN103601724A Novel oxazolidinone compound, as well as preparation method and application thereof
02/26/2014CN103601723A Industrial production method of azilsartan
02/26/2014CN103601674A Compounds for inhibiting dipeptide kininase, preparation method and applications thereof
02/26/2014CN102603724B Method for purifying and refining dimethoxy taxane compound
02/26/2014CN102516237B Oxazolidinone derivative
02/26/2014CN102471317B Aminopyridine derivatives for treating tumors and inflammatory diseases
02/26/2014CN102099352B STAT3 inhibitor containing quinolinecarboxamide derivative as active ingredient
02/25/2014US8658798 Herbicide triazolylpyridine ketones
02/25/2014US8658789 Method for preparing linezolid and intermediates thereof
02/25/2014US8658675 Pyridin-4-yl derivatives
02/25/2014US8658659 Substituted oxazole derivatives and their use as tyrosine kinase inhibitors
02/25/2014US8658654 Receptor-type kinase modulators and methods of use
02/25/2014US8658649 Kinase inhibitor
02/25/2014US8658641 Fused, spirocyclic heteroaromatic compounds for the treatment of bacterial infections
02/25/2014US8658639 N-substituted-cyclic amino derivative
02/25/2014US8658636 TRPV4 antagonists
02/25/2014US8658635 Benzpyrazol derivatives as inhibitors of PI3 kinases
02/25/2014CA2777632C Imidazole derivatives as casein kinase inhibitors
02/22/2014CA2787472A1 Protein kinase inhibitors
02/20/2014WO2014028669A1 Novel compounds for modulation of ror-gamma activity
02/20/2014WO2014028459A1 1,4-disubstituted pyridazine analogs and methods for treating smn-deficiency-related conditions
02/20/2014WO2014028025A1 Compositions and methods for treating myotonic dystrophy type 1
02/20/2014WO2014027081A1 Trisubstituted pyrido[2,3-d]pyrimidines, methods for preparing same and therapeutic uses thereof
02/20/2014WO2014026997A1 2,3-benzodiazepines
02/20/2014WO2014026928A1 Process for manufacturing benzoxazinones
02/20/2014WO2014026893A1 Carbamat-benzoxazinones
02/20/2014WO2014026845A1 Carbamates
02/20/2014WO2014026330A1 3-AMINOCYCLOALKYL COMPOUNDS AS RORgammaT INHIBITORS AND USES THEREOF
02/20/2014WO2014026243A1 Vegfr3 inhibitors
02/20/2014WO2013188771A3 Catalytic c-h bond activation
02/20/2014WO2013170068A3 Nuclear transport modulators and uses thereof
02/20/2014US20140051862 5-membered ring heteroaromatic derivatives having npy y5 receptor antagonistic activity
02/20/2014US20140051729 Compositions and methods for treating degenerative muscle conditions
02/20/2014US20140051727 Pyridonyl guanidine f1f0-atpase inhibitors and therapeutic uses thereof
02/20/2014US20140051709 Compositions and Methods for Treating Myotonic Dystrophy Type 1
02/20/2014US20140051703 Thiopyrimidine-based compounds and uses thereof
02/20/2014US20140051694 Aminooxazole Inhibitors of Cyclin Dependent Kinases
02/20/2014US20140051691 Oxazine derivatives and a pharmaceutical composition for inhibiting bace1 containing them
02/20/2014US20140051683 7-substituted indole mcl-1 inhibitors
02/20/2014US20140051682 Novel 1,2- bis-sulfonamide derivatives as chemokine receptor modulators
02/20/2014US20140051681 Mst1 kinase inhibitors and methods of their use
02/20/2014US20140051679 Kinase inhibitors and method of treating cancer with same
02/20/2014US20140051676 Triazine-oxadiazoles
02/20/2014US20140051673 AMPK-Activating Heterocycloalkyloxy(Hetero)Aryl Carboxamide, Sulfonamide And Amine Compounds And Methods For Using The Same
02/20/2014US20140051672 1,4-disubstituted pyridazine analogs there of and methods for treating smn-deficiency-related conditions
02/20/2014US20140051629 Modulators of the gpr119 receptor and the treatment of disorders related thereto
02/19/2014EP2698369A1 Benzopyrone derivative and use thereof
02/19/2014EP2697240A1 Glycoside derivatives and uses thereof
02/19/2014EP2697220A1 Chromenone compounds as pi 3 -kinase inhibitors for the treatment of cancer
02/19/2014EP2697219A1 Novel piperidinyl monocarboxylic acids as s1p1 receptor agonists
02/19/2014EP2697209A1 Method for the preparation of substituted oxazolidinones
02/19/2014EP2697208A1 1,3 oxazines as bace1 and/or bace2 inhibitors
1 ... 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 ... 647